Latest TCG Crossover Management, LLC Stock Portfolio
$901Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About TCG Crossover Management, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, TCG Crossover Management, LLC reported an equity portfolio of $679.1 Millions as of 30 Sep, 2023.
The top stock holdings of TCG Crossover Management, LLC are , COGT, GERN. The fund has invested 11.2% of it's portfolio in STRUCTURE THERAPEUTICS INC and 8.1% of portfolio in COGENT BIOSCIENCES INC.
The fund managers got completely rid off IVERIC BIO INC, ACLARIS THERAPEUTICS INC (ACRS) and ALPINE IMMUNE SCIENCES INC (ALPN) stocks. They significantly reduced their stock positions in IMMUNOVANT, INC (IMVT) and GERON CORP (GERN). TCG Crossover Management, LLC opened new stock positions in SAVARA INC. (SVRA), TAYSHA GENE THERAPIES, INC. (TSHA) and INHIBRX,INC (INBX). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, AN2 THERAPEUTICS, INC. (ANTX) and MADRIGAL PHARMACEUTICALS INC (MDGL).
The top stock holdings of TCG Crossover Management, LLC are , COGT, GERN. The fund has invested 11.2% of it's portfolio in STRUCTURE THERAPEUTICS INC and 8.1% of portfolio in COGENT BIOSCIENCES INC.
The fund managers got completely rid off IVERIC BIO INC, ACLARIS THERAPEUTICS INC (ACRS) and ALPINE IMMUNE SCIENCES INC (ALPN) stocks. They significantly reduced their stock positions in IMMUNOVANT, INC (IMVT) and GERON CORP (GERN). TCG Crossover Management, LLC opened new stock positions in SAVARA INC. (SVRA), TAYSHA GENE THERAPIES, INC. (TSHA) and INHIBRX,INC (INBX). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, AN2 THERAPEUTICS, INC. (ANTX) and MADRIGAL PHARMACEUTICALS INC (MDGL).
New Buys
| Ticker | $ Bought |
|---|---|
| TOURMALINE BIO INC | 26,386,900 |
| VISTAGEN THERAPEUTICS INC | 13,757,600 |
| ABIVAX SA | 11,770,000 |
| NURIX THERAPEUTICS INC | 7,406,190 |
| KODIAK SCIENCES INC | 814,540 |
New stocks bought by TCG Crossover Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| GRACELL BIOTECHNOLOGIES INC. | 48.57 |
| STRUCTURE THERAPEUTICS INC | 40.38 |
Additions to existing portfolio by TCG Crossover Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| TAYSHA GENE THERAPIES, INC. | -73.78 |
TCG Crossover Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| IMMUNOVANT, INC | -12,855,000 |
| MERUS N.V. | -7,074,000 |
TCG Crossover Management, LLC got rid off the above stocks
Current Stock Holdings of TCG Crossover Management, LLC
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 THERAPEUTICS, INC. | 6.09 | 2,678,210 | 54,876,500 | UNCHANGED | 0.00 | |
| AVTE | AEROVATE THERAPEUTICS INC | 5.53 | 2,201,270 | 49,814,800 | UNCHANGED | 0.00 | |
| CABA | CABALETTA BIO, INC | 1.23 | 486,795 | 11,050,200 | UNCHANGED | 0.00 | |
| CCCC | C4 THERAPEUTICS, INC. | 0.80 | 1,276,570 | 7,212,640 | UNCHANGED | 0.00 | |
| CMPS | COMPASS PATHWAYS PLC | 3.74 | 3,858,000 | 33,757,500 | UNCHANGED | 0.00 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1.80 | 2,040,820 | 16,244,900 | UNCHANGED | 0.00 | |
| COGT | COGENT BIOSCIENCES INC | 3.67 | 5,631,040 | 33,110,500 | UNCHANGED | 0.00 | |
| DYN | DYNE THERAPEUTICS, INC | 2.43 | 1,650,150 | 21,947,000 | UNCHANGED | 0.00 | |
| GERN | GERON CORP | 5.47 | 23,375,800 | 49,323,000 | UNCHANGED | 0.00 | |
| GRCL | GRACELL BIOTECHNOLOGIES INC. | 5.03 | 4,514,790 | 45,328,500 | ADDED | 48.57 | |
| ICVX | ICOSAVAX INC | 6.47 | 3,703,700 | 58,370,400 | UNCHANGED | 0.00 | |
| IMVT | IMMUNOVANT, INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| INBX | INHIBRX,INC | 7.38 | 1,750,390 | 66,514,700 | UNCHANGED | 0.00 | |
| KALV | KALVISTA PHARMACEUTICALS, INC | 4.61 | 3,395,500 | 41,594,800 | UNCHANGED | 0.00 | |
| KOD | KODIAK SCIENCES INC | 0.09 | 267,941 | 814,540 | NEW | ||
| KURA | KURA ONCOLOGY INC | 2.27 | 1,423,640 | 20,472,000 | UNCHANGED | 0.00 | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 4.62 | 179,917 | 41,629,200 | UNCHANGED | 0.00 | |
| MRUS | MERUS N.V. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NRIX | NURIX THERAPEUTICS INC | 0.82 | 717,654 | 7,406,190 | NEW | ||
| SLN | SILENCE THERAPEUTICS PLC | 4.06 | 2,104,880 | 36,561,700 | UNCHANGED | 0.00 | |
| SVRA | SAVARA INC. | 5.21 | 10,000,000 | 47,000,000 | UNCHANGED | 0.00 | |
| TARS | TARSUS PHARMACEUTICALS, INC. | 2.57 | 1,142,860 | 23,142,900 | UNCHANGED | 0.00 | |
| TRDA | ENTRADA THERAPEUTICS INC | 0.98 | 584,955 | 8,826,970 | UNCHANGED | 0.00 | |
| TSHA | TAYSHA GENE THERAPIES, INC. | 0.57 | 2,912,860 | 5,155,760 | REDUCED | -73.78 | |
| TYRA | TYRA BIOSCIENCES INC | 3.06 | 1,989,100 | 27,549,100 | UNCHANGED | 0.00 | |
| VSTA | VISTAGEN THERAPEUTICS INC | 1.53 | 2,676,580 | 13,757,600 | NEW | ||
| VTYX | VENTYX BIOSCIENCES, INC | 0.22 | 815,724 | 2,014,840 | UNCHANGED | 0.00 | |
| STRUCTURE THERAPEUTICS INC | 9.54 | 2,109,580 | 85,986,600 | ADDED | 40.38 | ||
| RAYZEBIO, INC. | 6.00 | 869,908 | 54,082,200 | UNCHANGED | 0.00 | ||
| TOURMALINE BIO INC | 2.93 | 1,007,900 | 26,386,900 | NEW | |||
| ABIVAX SA | 1.30 | 1,100,000 | 11,770,000 | NEW |